Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29484697 | 0.94 | GRM2 (1.00) | GRM2GRM3 | |
| SCHEMBL19508600 | 0.94 | GRM2 (1.00) | GRM2GRM3 | |
| SCHEMBL19508633 | 0.83 | GRM2 (0.62) | GRM2GRM3 | |
| SCHEMBL29484696 | 0.82 | GRM2 (0.76) | GRM2GRM3 | |
| SCHEMBL22130869 | 0.81 | GRM2 (0.59) | GRM2GRM3 | |
| SCHEMBL19508597 | 0.81 | GRM2 (0.90) | GRM2GRM3 | |
| SCHEMBL19508444 | 0.79 | GRM2 (0.90) | GRM2GRM3 | |
| SCHEMBL22130825 | 0.78 | GRM2 (0.55) | GRM2GRM3 | |
| SCHEMBL19508391 | 0.78 | GRM2 (0.55) | GRM2GRM3 | |
| SCHEMBL20730978 | 0.77 | GRM2 (0.55) | GRM2GRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3445743-B1 | PRODRUG OF AMINO ACID DERIVATIVE | TAISHO PHARMACEUTICAL CO LTD (JP) | 2021-08-04 | — | — | EP | disclosed |
| EP-3445743-B1 | PRODRUG OF AMINO ACID DERIVATIVE | TAISHO PHARMACEUTICAL CO LTD (JP) | 2021-08-04 | — | — | EP | disclosed |
| US-10689327-B2 | Prodrug amino acid derivative | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2020-06-23 | — | — | US | disclosed |
| US-10689327-B2 | Prodrug amino acid derivative | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2020-06-23 | — | — | US | disclosed |
| US-20190337887-A1 | PRODRUG OF AMINO ACID DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2019-11-07 | — | — | US | disclosed |
| US-10464884-B2 | Prodrug of amino acid derivative | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2019-11-05 | — | — | US | disclosed |
| US-20190047943-A1 | PRODRUG OF AMINO ACID DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2019-02-14 | — | — | US | disclosed |
| WO-2017183734-A1 | PRODRUG OF AMINO ACID DERIVATIVE | TAISHO PHARMACEUTICAL CO., LTD. (JP) | 2017-10-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10689327-B2 | Prodrug amino acid derivative | GRIN2A, SLC1A2, SLC1A1 | GRM2 12/4885GRM3 26/4885 |
| US-20190337887-A1 | PRODRUG OF AMINO ACID DERIVATIVE | GRIN2A, SLC1A2, SLC1A1 | GRM2 13/4885GRM3 28/4885 |
| US-10464884-B2 | Prodrug of amino acid derivative | GRIN2A, SLC1A2, SLC1A1 | GRM2 13/4885GRM3 28/4885 |
| US-20190047943-A1 | PRODRUG OF AMINO ACID DERIVATIVE | GRIN2A, SLC1A2, SLC1A1 | GRM2 13/4885GRM3 28/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.